Quercetin Ameliorates Lipid and Apolipoprotein Profile in High-Dose Glucocorticoid Treated Rats حسب Hoda Derakhshanian (10375162)

"…Apo B/A1 ratio decreased more than 20% following quercetin intake and the decline in TC/HDL, TG/HL, LDL/HDL ratios were significant. …"

Adverse events ^a. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Rhinorrhea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Vomit-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Symptoms free-days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Respiratory symptoms-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Other symptoms-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Diarrhea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Gastrointestinal symptoms-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Nausea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Baseline characteristics of the patients^a. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Flow of patients in Halos trial. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Cough-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Dyspnea-free days up to day 10. حسب Bruno Martins Tomazini (6509528)

"…</p><p>Conclusions</p><p>Among non-hospitalized adults with mild to moderate Covid-19 halofuginone treatment was safe and well tolerated but did not decrease SARS-CoV-2 viral load decay rate within 10 days.…"

Temporal and regional trends of antibiotic use in long-term aged care facilities across 39 countries, 1985-2019: systematic review and meta-analysis حسب Magda Raban (10556639)

"…Point prevalence varied significantly between regions (Q=224.1, df=7, p<0.001), and ranged from 2.4% (95% CI: 1.7-2.7) in Eastern Europe to 9.0% in the British Isles (95% CI: 7.6-10.5) and Northern Europe (95% CI: 7.7-10.5). …"

Table_1_Modeling decline of mountain range forest using survival analysis.docx حسب Thakur Dhakal (6748469)

"…The deforestation risks are significantly different among regions; protected areas lose less forest than non-protected areas but the losses in protected areas were also significant, with approximately 5% from 2000 to 2020. …"

Table_1_Modeling decline of mountain range forest using survival analysis.docx حسب Thakur Dhakal (6748469)

"…The deforestation risks are significantly different among regions; protected areas lose less forest than non-protected areas but the losses in protected areas were also significant, with approximately 5% from 2000 to 2020. …"

Antiangiogenic activity of photobiomodulation in experimental model using chorioallantoic embryonic membrane of chicken eggs حسب Lays Fernanda Nunes Dourado (6098738)

"…We treated the negative control group with 50 μl phosphate-buffered-saline (pH 7.4) and the positive control group (Beva) with 50 μl bevacizumab solution (Avastin, Produtos Roche Químicos e Farmacêuticos, S.A., Brazil). …"

Data Sheet 1_Predictive value of percutaneous peripheral arterial compliance T in left ventricular diastolic function with coronary artery disease.pdf حسب Wenhao Zhang (303192)

"…</p>Conclusions<p>When coronary artery stenosis exceeds 50%, there is a decrease in peripheral artery compliance, showing a positive correlation with changes in left ventricular diastolic function. …"

Table_3_The Thermal Tolerances, Distributions, and Performances of Tropical Montane Tree Species.pdf حسب Kenneth Feeley (732803)

"…We found that species' T₅₀ do in fact decrease with plot elevation but significantly slower than the corresponding adiabatic lapse rate (−0.4 vs. −5.7°C km⁻¹) and that there remains a large amount of unexplained variation in the thermal tolerances of co-occurring tree species. …"